Invenomic Capital Management’s ABM Industries ABM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.5M Sell
559,196
-70,256
-11% -$3.04M 0.99% 35
2025
Q4
$26.6M Buy
629,452
+129,614
+26% +$5.7M 1.24% 23
2025
Q3
$23.1M Buy
499,838
+231,988
+87% +$11M 1.12% 27
2025
Q2
$12.6M Buy
+267,850
New +$12.9M 0.72% 49
2024
Q2
Sell
-225,695
Closed -$10.1M 159
2024
Q1
$10.1M Buy
+225,695
New +$9.46M 0.54% 66
2023
Q1
Sell
-109,468
Closed -$4.86M 142
2022
Q4
$4.86M Sell
109,468
-149,348
-58% -$6.56M 0.33% 90
2022
Q3
$9.89M Buy
258,816
+109,793
+74% +$4.81M 0.85% 42
2022
Q2
$6.47M Buy
149,023
+5,973
+4% +$276K 0.46% 65
2022
Q1
$6.59M Buy
143,050
+97,773
+216% +$4.25M 0.7% 42
2021
Q4
$1.85M Buy
+45,277
New +$2.04M 0.4% 76

Other funds holding ABM

Invenomic Capital Management's ABM Position: Q1 2026 in Review

Invenomic Capital Management reduced its ABM Industries (ABM) stake by 11% in Q1 2026, selling an estimated $3.04M and leaving 559,196 shares worth $21.5M. The position accounts for 0.99% of the portfolio, ranked #35.

Invenomic Capital Management first reported a position in ABM in Q4 2021 and has held it in 10 quarters since. The position peaked at $26.6M in Q4 2025. 287 funds tracked by Wall St. Rank hold ABM as of Q1 2026.

  • Invenomic Capital Management held 559,196 shares of ABM Industries worth $21.5M as of Q1 2026.
  • Invenomic Capital Management sold 70,256 ABM Industries shares in Q1 2026, an estimated $3.04M.
  • ABM Industries made up 0.99% of Invenomic Capital Management's portfolio in Q1 2026, its #35 holding.
  • Invenomic Capital Management first reported a position in ABM Industries in Q4 2021 and has held it in 10 quarters since.
  • Invenomic Capital Management's ABM Industries position peaked at $26.6M in Q4 2025.
  • 287 funds tracked by Wall St. Rank held ABM Industries as of Q1 2026.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.